US$ 26.53
glp-1 drugs and breast cancer Receptor Agonists in Cancer: A New Frontier in Obesity Prognosis Management GLP-1 Drugs May Improve Survival
Description
10.1210/jcem-50-1-113 J Clin Endocrinol Metab

Writingoriginal draft preparation: J.J.G.-M
This risk applies to any weight-loss method whether diet-based or medication-assisted

[Content Brief] [2]
On the other hand, exenatide did not affect endothelial function in rat conduit arteries when tested ex vivo after intralipid infusion [107, 108]

Diabetes Care 15, 270276 (1992)
